These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 30793226)

  • 1. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.
    Al-Rugeebah A; Alanazi M; Parine NR
    Pathol Oncol Res; 2019 Jul; 25(3):859-874. PubMed ID: 30793226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA.
    Ghafouri-Fard S; Taheri M
    Biomed Pharmacother; 2019 Oct; 118():109129. PubMed ID: 31326791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.
    Sun M; Xia R; Jin F; Xu T; Liu Z; De W; Liu X
    Tumour Biol; 2014 Feb; 35(2):1065-73. PubMed ID: 24006224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212.
    Yu F; Geng W; Dong P; Huang Z; Zheng J
    Cell Death Dis; 2018 Oct; 9(10):1014. PubMed ID: 30282972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA-ATB: An indispensable cancer-related long noncoding RNA.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28884871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.
    Xin Y; Li Z; Shen J; Chan MT; Wu WK
    Cell Prolif; 2016 Jun; 49(3):255-60. PubMed ID: 27134049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in Gastric Cancer.
    Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y
    Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression.
    Peng W; Si S; Zhang Q; Li C; Zhao F; Wang F; Yu J; Ma R
    J Exp Clin Cancer Res; 2015 Aug; 34(1):79. PubMed ID: 26253106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
    Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
    Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZEB1-AS1: A crucial cancer-related long non-coding RNA.
    Li J; Li Z; Leng K; Xu Y; Ji D; Huang L; Cui Y; Jiang X
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of long noncoding RNA MEG3 with miRNAs: A reciprocal regulation.
    Moradi MT; Fallahi H; Rahimi Z
    J Cell Biochem; 2019 Mar; 120(3):3339-3352. PubMed ID: 30230601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
    Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
    Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.
    Zhang J; Yao T; Wang Y; Yu J; Liu Y; Lin Z
    Cancer Biol Ther; 2016; 17(1):104-13. PubMed ID: 26574780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer.
    Li H; Zhu L; Xu L; Qin K; Liu C; Yu Y; Su D; Wu K; Sheng Y
    Mol Carcinog; 2017 Jan; 56(1):3-17. PubMed ID: 26207516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3.
    Xiu YL; Sun KX; Chen X; Chen S; Zhao Y; Guo QG; Zong ZH
    Oncotarget; 2017 May; 8(19):31714-31725. PubMed ID: 28423647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
    Sun L; Li Y; Yang B
    Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers.
    Han W; Yu F; Guan W
    Biomed Pharmacother; 2020 Oct; 130():110632. PubMed ID: 34321169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.